Waters (WAT) Competitors $301.93 +11.49 (+3.96%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$302.30 +0.37 (+0.12%) As of 08/22/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock WAT vs. BRKR, TECH, A, DHR, IQV, MTD, RVTY, TMO, ILMN, and CRLShould you be buying Waters stock or one of its competitors? The main competitors of Waters include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Illumina (ILMN), and Charles River Laboratories International (CRL). Waters vs. Its Competitors Bruker Bio-Techne Agilent Technologies Danaher IQVIA Mettler-Toledo International Revvity Thermo Fisher Scientific Illumina Charles River Laboratories International Bruker (NASDAQ:BRKR) and Waters (NYSE:WAT) are both life sciences tools & services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Do insiders and institutionals believe in BRKR or WAT? 79.5% of Bruker shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 27.3% of Bruker shares are owned by insiders. Comparatively, 0.6% of Waters shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer BRKR or WAT? In the previous week, Waters had 37 more articles in the media than Bruker. MarketBeat recorded 48 mentions for Waters and 11 mentions for Bruker. Bruker's average media sentiment score of 1.59 beat Waters' score of 0.71 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Waters 22 Very Positive mention(s) 7 Positive mention(s) 11 Neutral mention(s) 6 Negative mention(s) 2 Very Negative mention(s) Positive Which has better valuation & earnings, BRKR or WAT? Waters has lower revenue, but higher earnings than Bruker. Waters is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.60$113.10M$0.5268.35Waters$3.05B5.90$637.83M$11.0927.23 Which has more volatility & risk, BRKR or WAT? Bruker has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, Waters has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Is BRKR or WAT more profitable? Waters has a net margin of 21.71% compared to Bruker's net margin of 2.31%. Waters' return on equity of 38.60% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 17.89% 5.38% Waters 21.71%38.60%15.87% Do analysts recommend BRKR or WAT? Bruker presently has a consensus price target of $51.30, indicating a potential upside of 44.34%. Waters has a consensus price target of $378.73, indicating a potential upside of 25.44%. Given Bruker's higher possible upside, equities research analysts clearly believe Bruker is more favorable than Waters.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45Waters 0 Sell rating(s) 9 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.47 SummaryWaters beats Bruker on 10 of the 16 factors compared between the two stocks. Get Waters News Delivered to You Automatically Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WAT vs. The Competition Export to ExcelMetricWatersMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$17.99B$7.05B$5.81B$21.31BDividend YieldN/A1.21%4.39%3.54%P/E Ratio27.2327.4531.3629.10Price / Sales5.9069.66387.8754.41Price / Cash19.9821.9338.0224.09Price / Book8.326.889.535.47Net Income$637.83M$176.42M$3.26B$992.74M7 Day Performance3.53%1.45%2.14%2.67%1 Month Performance1.15%-1.85%3.22%2.35%1 Year Performance-11.82%9.53%30.18%10.76% Waters Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WATWaters4.8284 of 5 stars$301.93+4.0%$378.73+25.4%-11.8%$17.99B$3.05B27.237,600Trending NewsBRKRBruker4.9679 of 5 stars$34.24+2.1%$51.30+49.8%-44.6%$5.19B$3.37B65.8511,396Positive NewsTECHBio-Techne4.847 of 5 stars$53.29-0.6%$69.42+30.3%-21.0%$8.35B$1.22B115.853,100News CoveragePositive NewsDividend AnnouncementAnalyst UpgradeAAgilent Technologies4.8806 of 5 stars$118.44-0.6%$139.77+18.0%-13.7%$33.65B$6.51B29.2417,900News CoveragePositive NewsUpcoming EarningsDHRDanaher4.7418 of 5 stars$209.32-0.8%$247.61+18.3%-21.4%$149.88B$23.88B44.5463,000News CoveragePositive NewsIQVIQVIA4.8933 of 5 stars$192.58+0.8%$228.62+18.7%-23.3%$32.74B$15.41B27.8788,000News CoverageShort Interest ↓MTDMettler-Toledo International4.0007 of 5 stars$1,315.45+0.2%$1,288.89-2.0%-8.0%$27.10B$3.87B33.3117,300News CoveragePositive NewsAnalyst ForecastInsider TradeRVTYRevvity3.5649 of 5 stars$89.72-1.2%$120.07+33.8%-22.4%$10.41B$2.76B38.0211,000News CoveragePositive NewsTMOThermo Fisher Scientific4.9172 of 5 stars$488.15-0.2%$593.00+21.5%-17.5%$184.33B$42.88B28.23125,000Trending NewsInsider TradeAnalyst RevisionILMNIllumina4.6537 of 5 stars$100.53+0.4%$124.58+23.9%-22.5%$15.45B$4.37B12.739,030Positive NewsCRLCharles River Laboratories International4.0119 of 5 stars$157.27+0.4%$175.69+11.7%-21.3%$7.74B$4.05B-118.2520,100News CoveragePositive NewsInsider Trade Related Companies and Tools Related Companies BRKR Competitors TECH Competitors A Competitors DHR Competitors IQV Competitors MTD Competitors RVTY Competitors TMO Competitors ILMN Competitors CRL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:WAT) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waters Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Waters With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.